chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Started feeling fatigued, congested and with a headache; Went to get a COVID-19 PCR test and it was positive; Prescribed PAXLOVID.
PT BECAME PALE, WEAK AND DIZZY AFTER ADMINISTERING HPV VACCINE. PT REPORTED FEELING COLD AFTER ADMINISTRATION. PT WAS SITTING AT TIME ON INNOCULATION.
hands and feet had turned red, swollen slightly with severe itching; hands and feet had turned red, swollen slightly with severe itching; hands and feet had turned red, swollen slightly with severe itching; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 11 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 08Nov2021 15:00 (Lot number: fk5127) at the age of 11 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: FLU. The following information was reported: ERYTHEMA (non-serious), PERIPHERAL SWELLING (non-serious), PRURITUS (non-serious) all with onset 09Nov2021, outcome "not recovered" and all described as "hands and feet had turned red, swollen slightly with severe itching". The event "hands and feet had turned red, swollen slightly with severe itching", "hands and feet had turned red, swollen slightly with severe itching" and "hands and feet had turned red, swollen slightly with severe itching" was evaluated at the physician office visit. Therapeutic measures were taken as a result of erythema, peripheral swelling, pruritus.  Additional Information: Within 24 hours hands and feet had turned red, swollen slightly with severe itching. Some itchy red skin elsewhere on body. Treatment received with antihistamines, topical cream. No Other medications in two weeks. No Covid prior vaccination and No Covid tested post vaccination and No Known allergies.
The CMA spoke with the mother of the patient on 03/21/01, the patient is doing fine. The CMA explained to the mother the need for the patient to receive DTaP at her 5 year visit.
8 days after the shot developed intense itching and hives 2cm around injection site. Itching and hives lasted about 1 1/2 hour
pATIENT RECEIVED A COVID VACCINE WHEN SHE WASN'T ELIGIBLE TO RECEIVE AN ADDITIONAL DOSE
During my cardiac rehab exercise program, my heart rate jumped up to 150+ much higher than allowable. Exercise was slowed and finally stopped. Rapid heart rate returned to normal around 6-7 PM that evening.
NSTEMI (non-ST elevated myocardial infarction) (CMS/HCC). PFIZER Lots # EL 9269, EN6200.
Pfizer-BioNTech COVID-19 Vaccine EUA injection site pain, minor nausea, minor headache starting 4 hours after vaccine administration injection site pain, fatigue, worsening headache, body aches (muscle pain), chills, worsening nausea starting approximately 30 hours after vaccine administration
This case was reported by a pharmacist via call center representative and described the occurrence of heart disease, unspecified in a 62-year-old male patient who received SHINGRIX (batch number XC534, expiry date 4th July 2020). The patient's past medical history included hypertension and diabetes. On 27th March 2018 11:30, the patient received SHINGRIX. On 27th March 2018 18:00, 6 hrs 30 min after receiving SHINGRIX, the patient experienced heart disease, unspecified (serious criteria death). On 27th March 2018 18:00, the outcome of the heart disease, unspecified was fatal. The patient died on 27th March 2018. The reported cause of death was heart disease, unspecified. It was unknown if the reporter considered the heart disease, unspecified to be related to SHINGRIX. Additional details were provided as follows: At 6 pm, the patient passed away. The healthcare professional explained that the coroner reported that the patient passed away due to heart issues etc. The pharmacist was sure that the patient also passed away due to heart issues. The pharmacist called into medical information to confirm that other patients had not passed away due to the SHINGRIX vaccine.
Patient went to urgent care - soreness and swelling under left deltoid - ARNP gave prescription for ibuprofen 600 mg and to place hot compress on site - left axillary lymphadenitis.
Patient with HA / "Mucous" sensation in throat. Progressed to patient frequently coughing / clearing throat. Felt like something in throat, difficult to swallow water  ICC called for ER MD to eval. IV started. Benadryl, Pepcid, and Solumedrol given as per protocol. Pt taken to ICC for monitoring.
This spontaneous report as received from a licensed practical nurse via a company representative refers to a 15 year old, non-pregnant female patient. The patient's concurrent conditions, medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated with a first dose of GARDASIL, intramuscularly (site of administration, lot # and expiry date were not reported). In 2012 (also reported as after receiving the dose of GARDASIL,), the patient experienced unspecified seizure. The patient did not receive the second or the third dose of GARDASIL. The outcome of seizure was unknown. The patient sought medical attention via contacting the nurse. The relatedness between the event and the suspect therapy was not provided. Upon internal review the event of seizure was considered medically significant. Additional information has been requested.
Swelling of throat and tongue. Numbness of lips, throat, and tongue. Presented to ED with a suspected allergic reaction to the first dose of the pfizer vaccine.  Pt received the vaccine at 0800 and approximately 10 minutes later, she developed swelling of the back of her tongue and lip numbness.  Pt was given Benadryl at the vaccination clinic and was released w/ instructions to call her PCP.  Pt called her PCP who referred her to the ED.  Pt denies any chest pain at this time.  Pt also had a little shortness of breath and nausea when her allergic reaction first started. Observed for 5 hours and discharged from ED.
Suspected vaccination failure; After each shot I have had an outbreak of shingles.; After each shot I have had an outbreak of shingles.; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and shingles. On an unknown date, the outcome of the vaccination failure, shingles and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix. It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient reported that he/she had both Shingrix shots and had shingles, after each shot the patient had an outbreak of shingles and wanted to know if it was normal. This case was considered as suspected vaccination failure as details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up would not be possible as no contact details were available.
Patient called 2 1/2 weeks after receiving flu shot to say that since the evening after the vaccination he was experiencing pain in that shoulder, and instead of getting better, the pain was actually increasing and now causing decreased range of motion.
This case was reported by a nurse via call center representative and described the occurrence of injection site pain in an unspecified number of the patients who received RABAVERT for prophylaxis. On an unknown date, the patient received RABAVERT at an unknown dose. On an unknown date, unknown after receiving RABAVERT, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown. It was unknown if the reporter considered the injection site pain to be related to RABAVERT. Additional details were provided as follows: It was unknown whether the patient received RABAVERT for pre or post exposure prophylaxis. The age at vaccination was not applicable for this report. The healthcare professional made a general statement about how most patients did not report many adverse events after receiving RABAVERT except soreness at the injection site.
DIARRHEA, POSITIVE COVID TEST, HX OF DIABETES AND HTN; SEIZURE DISORDER
Sore arm; Let's take a half dose of Afluria Quadrivalent and two weeks later the other half; This spontaneous case was received on 24-Oct-2022 from other non-healthcare professional (consumer) via Agency (reference number: SEQW22-04974) with additional information (being processed together) received via Agency on the same day, from an other non-healthcare professional (consumer) and concerned an elderly  (over 65 years of age) female patient,  The patient's concurrent conditions included asthma and thimerosal allergy. The patient's historical conditions included flu, over the period of 10 years when the patient stopped taking the flu vaccine. The patient's concomitant medications included an unspecified inhaler. The patient's historical vaccines included multiple influenza virus vaccines (brand not specified) on unspecified dates '20/30 years ago', for unreported indication, however, one year the patient got very sick (see linked case: 202206184). At some point her doctor said that she 'cannot have this anymore'.  On an unspecified date in Oct-2022, the patient was vaccinated with Afluria Quadrivalent (influenza vaccine inact sag 4v; dose: reported as half dose; route of administration and anatomical location were not reported) for active immunization against influenza disease caused by influenza virus subtypes A and B. The batch number was not reported, As reported, the doctor came up to the patient and stated that she should take a half dose of Afluria Quadrivalent and two weeks later the other half.   On 19-Oct-2022 the patient was vaccinated with Afluria Quadrivalent (influenza vaccine inact sag 4v; dose: reported as 0.5 ml and  'full dose'; route of administration and anatomical location were not reported) (explicitly codded as 'Product administration error') for active immunization against influenza disease caused by influenza virus subtypes A and B. The batch number was not reported.  On an unspecified date in October 2022, after receiving half a dose of Alfuria Quadrivalent, patient experienced a sore arm.  The outcome of the events was not reported.  The reporter did not provide causality assessment.   The case was assessed as non-serious.  The case is linked to 202206184 (the same patient and reporter).  Company comment: The event of pain in arm  is assessed as possibly related to Afluria Quadrivalent due to plausible temporal relationship. Product administration error is assessed as not related to Afluria Quadrivalent  as per company conventions.; Sender's Comments: The event of pain in arm  is assessed as possibly related to Afluria Quadrivalent due to plausible temporal relationship. Product administration error is assessed as not related to Afluria Quadrivalent  as per company conventions.
pt recvd vax; c/o muscles aches, body stiffness & soreness of inject site 24 hrs later; given acetaminophen for sxs;
My daughter is 16 yrs old and on Feb 27, 2008 had her first HPV vaccine and the second one April 24, 08. On June 14-08 I heard my dog barking in the living room I went to see what he was barking at and I found my daughter lying on the carpet having a seizure. At the time this was happening I did not know she was having a seizure because she doesn't have a history of seizure problems. I thought my daughter was dying in my arms of course I dialed 911 and she was taken to the Emergency room. We have under gone several tests CAT scan, EEG, MRI, spinal tap, blood work and currently seeing a neurologist. The test have came back all negative and now she has to take medicine for epilepsy. The first medicine the ER put her on was phenytoin sodium. Now she is taking Keppra., I had ask her primary doctor if there could be some connection to having taking the HPV vaccine her answer was that there has been no evidence or research to prove that the HPV vaccine can cause seizures. The doctor also said she probably has epilepsy. Wow this has been my daughter's doctor since she was 5 yrs old. My daughter is an outgoing teenager who has plans to graduate from high school and go on to a 4 year college. She is active in sports and plays the violin. I would definitely like to know why the medical field will not even consider that the HPV vaccine may have cause the complications.  11/19/08 MR received from PCP which include neuro consult. Seen 6/16/08 in F/u for ER visit 6/14/08 with DX: Seizure/Probable Epilepsy. Started on phenytoin in ER.  Seen 7/10/08, now on Keppra. Seen for brownish scaley macules on back, chest, neck.  Dx:  Seizure d/o.  Tinea versicolor. Seen 7/14/08 for c/o back pain. PE (+) for decreased ROM upon flexion. Dx: Muscle spasm. Neuro consult dated 6/24/08 for eval of generalized tonic-clonic seizure on 6/14/08 and another on the morning of the exam. No memory of event. Headache and tiredness after. PE WNL. Sent for MRI. 12/2/08 Additional records received from Neuro. No new codes.
No adverse event; An expired dose of ROTATEQ was inadvertently administered to a patient. No additional AE details or PQC.; This spontaneous report was received from  an office manager, and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On 07-APR-2022, the patient was inadvertently vaccinated with an expired dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, 2 milliliter, lot number: T034512, administered orally for prophylaxis (strength was not provided). The dose expired on 25-MAR-2022. No adverse events were reported.
Developed pericardial effusion and pneumonia. Pneumonia was diagnosed first on 09/08/2021 with a chest xray. I was given antibiotics prior to the actual diagnosis, for a 2 week period which didn't eliminate my symptoms (shortness of breath, fever, cough, resting heart rate of 115). Had a CT scan on 09/16/2021 which confirmed pericardial effusion. I was given Ibuprofen and colchicine which ultimately got me better.
SWEATING AND DIZZINESS. SHE HAD TO LAY DOWN AND PUT HER FEET UP.   NORMAL BLOOD PRESSURE VIALS.
I had a steroid shot in my shoulder two days before the vaccine. I have have mild to moderate headache, muscle aches and fatigue for seven days after receiving the vaccine. This was my first Covid vaccine.
Heart problems; This spontaneous case was reported by a consumer and describes the occurrence of CARDIAC DISORDER (Heart problems) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CARDIAC DISORDER (Heart problems). At the time of the report, CARDIAC DISORDER (Heart problems) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
mouth sores; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of STOMATITIS (mouth sores) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History Information was reported.  Concomitant products included GUSELKUMAB (TREMFYA) for an unknown indication.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) at an unspecified dose. On an unknown date, the patient experienced STOMATITIS (mouth sores). At the time of the report, STOMATITIS (mouth sores) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided
Swollen supraclavicular lymph nodes on side of vaccine. Have not gone down after four weeks.
11/04/22 I started having pressure in my bladder. It continued until I went to the Urgent Care on 11/12/22 thinking I had an UTI. They ran a urinalysis, pelvic exam that showed some tenderness on my left side ovary. The urinalysis came back negative for any bacteria. I did not receive any medication. I am waiting prior authorization for an ultrasound of my pelvic region.
Patient presented to a local ED with symptoms of chills, increased cough from baseline, muscle aches and pains, and fatigue.  Chest x-ray showed bibasilar opacities. COVID-19 Negative. Patient fully vaccinated with Moderna on 1/8/21, 2/5/21, and boosted on 11/23/21. Patient admitted to hospital service at a local HCF 11/26/21 and discharged on 11/28/21.
death Narrative:  Patient received Moderna COVID vaccine #1 on 1/10/21, he was seen by his PCP for a routine 6 month check up on 1/14/21. Notes at that time indicate he had a left great toe, he wound and was receiving home health and IV daptomycin through a PICC line. On 2/7/21, he received vaccine #2. Notes then indicate that on 3/9/21, he was found passed away in his home by family. No autopsy results available. 30 days form date of vaccine #2 to date of death.
Patient brought in by mother who stated she noticed patient's arm this morning. Patient's arm noted to have redness and to be warm to the touch. Treated with ice and antihistamine. Patient alert and no signs of discomfort. Patient to follow up in the morning.
Burning sensation on inside of arm where injection was given. Some swelling and redness in upper arm.  All symptoms lasted 3 days.
Information has been received from a t3 year old female patient referring to herself. The patient's medical history was not reported. The patient did not have drug reactions/allergies. On 22-JUN-2015 (reported as 4 days ago) the patient was vaccinated with ZOSTAVAX (lot #, expiration date, route and dose were unknown), 1 time vaccine) in the left ar. Concomitant therapies included metoprolol. On 25-JUN-2015 (reported as yesterday), the patient experienced "about a silver dollar sized, red, raised lump, with fever", at the insertion site, on her left arm. The patient did not seek for medical attention. The outcome of the event was unknown. Additional information is not expected as there is no contact information.
Pt. dvlped tingling,sensory loss,& weakness in lt hand.This progressed to rt UE & lt UE on 11/14/99.On 11/16 it progressed to rt LE,11/18 progressed to lt LE.Tx w/ NSAIDs but still experiencing sensory loss & muscle weakness.
Shortly after patient received vaccine (<5 min) mom reports patient looked pale, eyes rolled back and brief LOC. Mom called out for help. Pt was pale and diaphoretic. We attempted to lay her down and she had some trouble following directions. EMS was called. She sat up and was able to answer questions. She continued to look pale. Water was given. EMS arrived and transported patient to hospital for further evaluation.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 04-DEC-2013, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided) at a health department, as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 22-JUL-2016, the patient was treated by a hospital for a vesicular outbreak, which was diagnosed as herpes zoster or shingles. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
I had a similar experience with the 2nd vaccination. I had swelling in both wrists with pain associated. I also had swelling in my left ankle. They put me on metformin. Then I was given a standby prescription by my rheumatologist for prednisone if the situation happened again. After the 4th vaccine I had the same symptoms and used the prednisone prescription to combat it. The worst thing was that I was not bale to walk properly and do any kind of activity using my wrists and it stopped me from doing my normal routine. The pain and swelling is gone.
Pt has a swelling on her lt arm. Mom notice today. Pt not complaining any itchiness or pain.
Pain in thyroid started about 2 hours after getting the new booster on 9/8/2022. It is still sore 2 days after. I also had thyroid pain 1 week after 1st dose of Moderna vaccine on 4/10/2021 and what felt like athyroid nodule. It seemed to get worse after 2nd dose and got better after 6 months without vaccination (lump gotmsmaller and stopped being sore). I reported the symptoms last year but was not sure it was connected to the vaccine. Due to extenuating circumstances, I did not see a doctor and might not see a doctor for several weeks or months from now.
Erythema and firmness surrounding injection site, advised use of cool compresses and ibuprofen as needed.
The pt complained of funny taste in mouth, palate, tingling in back of head. Went to ER on 1/3/01 and 1/10/01. Complained of decreased circulation in LUE and LLE.
Information has been received from a registered nurse, for the Pregnancy Registry for GARDASIL, concerning an 18 year old female who on 14-JAN-2008 was vaccinated intramuscularly with first 0.5mL vaccine (lot number 659653/1448U).  Concomitant therapy included NUVARING.  On 24-MAR-2008 the patient was vaccinated intramuscularly with the second dose of GARDASIL (lot number 658556/1060U).  Subsequently, she became pregnant.  The patient was hospitalized for delivery.  On 16-JAN-2009 the patient delivered a baby boy who was 9 pounds and 4 ounces with APGAR of 9 and 9.  The reporter mentioned that during labor there was "meconuim staining to the amniotic fluid".  On 26-FEB-2009, the patient received the third dose of GARDASIL vaccine during a postpartum visit.  Additional information has been requested.
local soreness, abnormal headaches, dizziness, lightheaded, some ringing in ears, loss of memory, mild joint aches,stiffness in joints.
9JUN93 reported 15th day p/vax t103- 16th day t100- 17th day t103.6, rash on shoulders, face; called MD recommended lab tests for lead & UA as temp had gone to 104; lab tests were neg for lead & urine; MD stated ? react to MMR for viral inf
Left chest pain and pressure, extending into left arm, back and into jaw line.  Shortness of breath, non productive cough, nausea and vomiting. Symptoms worsen when laying flat or of up walking around. Swollen feet and legs.  Still experiencing systems.  Completed course of antibiotics, predniSONE 20 MG tablet,  and toradol. Currently resuming Motrin 3x a day, albuterol sulfate 90 mcg inhaler,   Pulmicort Flexhaler 180 mcg/actuation inhaler,  ondansetron ODT 4 MG disintegrating tablet, benzonatate 100 MG capsule